Formerly known as Seven Pebbles, Systems Analytics is a bioinformatics company serving government, pharmaceutical and biotechnology industry and academic research institutions for the discovery and evaluation of biomarkers of clinical and scientific significance. The firm specializse in state-of-the-science data mining, pattern recognition, and uncertainty analysis computational algorithms for the analysis of high throughput biological data such as genomics, proteomics, metabolic profiling, and their integration in a Systems Biology approach. The firm provide computational support to biologists in the elucidation of the molecular mechanisms of various pathological conditions including cancer and to facilitate the identification of novel biomarkers with potential in early diagnosis, prognosis, treatment response, and management of human diseases. Systems Analyticsâ bioinformatics capabilities that performs integrated analysis with genomics, proteomics, and metabolomics data profiles obtained from sources such as blood/plasma, urine, biopsy/tissue, spinal fluid, etc, and provides needed information to users from a large variation of applications in a systems biology approach. Systems Analyticsâ mission is to discover biomarkers of clinical and scientific significance by developing, improving and applying genomics, proteomics, metabolomics, and bioinformatics technologies. The objective of the discovery will focus on biomarkers for the early detection, treatment, and management of disease and toxicological effects upon external and internal impact, and on the understanding of the biological mechanism
